Wei Ni

8PUBLICATIONS
16CO-AUTHORS
Molecular targetsHaematologyGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 02, 2026
Renal cell carcinoma: molecular understanding and therapeutic development.

|May 30, 2024
BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation.

Swati Garg, Wei Ni, Basudev Chowdhury

|Apr 13, 2024
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma.

Basudev Chowdhury, Swati Garg, Wei Ni

|Nov 21, 2023
Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations.

Swati Garg, Wei Ni, James D Griffin

|Jul 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.

Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng

|Jan 17, 2022
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.

Jing Yang, Ellen L Weisberg, Shuang Qi

Pageof 2

Frequent Collaborators

5 joint publications

Martin Sattler

3 joint publications

Ellen Weisberg

3 joint publications

James D Griffin

2 joint publications

Swati Garg